Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gynecologic 1

Conditions

Breast Neoplasms 10Prostatic Neoplasms 6Multiple Myeloma 6Neoplasms 3Hematologic Neoplasms 3Carcinoma, Hepatocellular 3Papillomavirus Infections 2Neoplasm Metastasis 2Melanoma 2Leukemia, Myeloid, Acute 2Venous Thromboembolism 1Tumor Lysis Syndrome 1Thyroid Neoplasms 1Thyroid Diseases 1Thalassemia 1Squamous Cell Carcinoma of Head and Neck 1Skin Substitutes 1Skin Neoplasms 1Pulmonary Embolism 1Primary Myelofibrosis 1Post-operative Seroma Formation 1Polycythemia Vera 1Parathyroid Diseases 1Overweight 1Osteoradionecrosis 1Opioid-Related Disorders 1Oligodendroglioma 1Obesity 1Neutropenia 1Neurofibromatosis 1 1

Interventions

semaglutide 1Resistance Training 1Progestins 1Nutrition Assessment 1Megestrol Acetate 1Medroxyprogesterone Acetate 1Magnetic Resonance Spectroscopy 1Hysteroscopy 1Estrogen Replacement Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Overweight × 30 days × Clear all
NCT07462663 2026-05-13

SHAPE-ENDO

Hospital Universitari de Bellvitge

Phase 4 Not yet recruiting
82 enrolled
GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡